Filing Flows › Biogen (BIIB) › Net income
Biogen (BIIB) net income by quarter
Biogen's net income was $97.5M in Q2 2026 (second quarter 2026), -69% from Q1 2026. Over the last 5 quarters it ranged from $97.5M (Q2 2026) to $635M (Q2 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $97.5M | -69% | -85% |
| Q1 2026 | $320M | -32% | +33% |
| Q3 2025 | $466M | -27% | — |
| Q2 2025 | $635M | +164% | — |
| Q1 2025 | $240M | — | — |
Q2 2026 at a glance
Biogen, Q2 2026: revenue $2.7B (+3% year over year), operating margin 4.8%, net earnings $97.5M, operating cash flow $449M. The chart follows the revenue to costs, profit and cash.
Questions
What is Biogen's net income?
Biogen's net income was $97.5M in Q2 2026 (second quarter 2026), -69% from Q1 2026.
How has Biogen's net income changed?
Over the last 5 quarters it ranged from $97.5M (Q2 2026) to $635M (Q2 2025).